“The continued survival trend in this setting, alongside promising combination data, reinforces osimertinib as an effective and safe treatment for patients across stages of EGFR-mutated lung ...

Assessment of proteinuria in addition to estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD) may help identify individuals at high risk of adverse outcomes ...

safe and convenient treatment for patients with EGFR-mutated lung cancer across stages and lines of treatment.” Susan Galbraith, Executive Vice President, Oncology Hematology R&D, AstraZeneca ...

safe and convenient treatment for patients with EGFR-mutated lung cancer across stages and lines of treatment." Susan Galbraith, Executive Vice President, Oncology Hematology R&D, AstraZeneca, said: ...